Search - tctmd.com

Displaying 1 - 10 of 10

Sort: Relevancy | Date

Presentation THT 2025

Safety and Feasibility of Renal Venous Afterload Modulation With the Doraya in Acute Decompensated Heart Failure and Persistent Congestion From Insufficient Response to Diuretic Therapy

Presenter: Lucas Zier

February 13, 2025

Presentation THT 2025

Safety and Efficacy of the preCARDIA System to Mechanically Reduce Cardiac Preload for Acutely Decompensated Heart Failure: The Expanded VENoUS Heart Failure (VENUS-HF) Early Feasibility Study

Presenter: Navin Kapur

February 12, 2025

Presentation TCT 2024

TCT 467: Prolonged Occlusion of the Superior Vena Cava Using the PreCardia System Reduces Cardiac Filling and Renal Venous Pressures Without Causing Cerebral Injury in a Preclinical Model of Systemic Congestion

Presenter: Navin Kapur

October 28, 2024

Presentation THT 2024

Safety and Feasibility Assessment of the Doraya, a Renal Venous Afterload Modulator, for the Treatment of Volume Overload in Acute Heart Failure Patients with Insufficient Response to Diuretics

Presenter: Lucas Zier

March 06, 2024

Presentation THT 2023

The Nephronyx Perfuser: A Novel Device That Targets Increased Renal Venous Pressure in Patient With Cardiorenal Syndrome

Presenter: Oren Caspi

March 21, 2023

Presentation TCT 2022

Pulmonary to Venous Shunt for Group 2 PH-HFpEF (NXT™ Rivet)

Presenter: Rob Taft

September 17, 2022

Presentation THT 2022

Utilization of Left-Atrial Venous Arterial Extracorporeal Membrane Oxygenation for Biventricular Failure in Cardiogenic Shock

Presenter: Waleed Al-Darzi

February 02, 2022

Presentation TCT 2019

Reducing Renal Venous Pressure: Revamp/Doraya Infra-Renal Vein Flow Regulator

Presenter: Ulrich Jorde

September 28, 2019

Medically Ill Pa+ent Assessment of Rivaroxaban Versus Placebo IN Reducing Post-Discharge Venous Thrombo-Embolism Risk (MARINER) Trial: Primary Results

Presentation ESC 2018

Medically Ill Patient Assessment of Rivaroxaban Versus Placebo IN Reducing Post-Discharge Venous Thrombo-Embolism Risk (MARINER) Trial: Primary Results

Presenter: Alex C. Spyropoulos

August 27, 2018

Presentation

Prevention of Contrast-Induced Nephropathy by Central Venous Pressure (CVP)-Guided Fluid Administration

Presenter: G. Qian

December 08, 2015

Advertisement

Safety and Feasibility of Renal Venous Afterload Modulation With the Doraya in Acute Decompensated Heart Failure and Persistent Congestion From Insufficient Response to Diuretic Therapy

Safety and Efficacy of the preCARDIA System to Mechanically Reduce Cardiac Preload for Acutely Decompensated Heart Failure: The Expanded VENoUS Heart Failure (VENUS-HF) Early Feasibility Study

TCT 467: Prolonged Occlusion of the Superior Vena Cava Using the PreCardia System Reduces Cardiac Filling and Renal Venous Pressures Without Causing Cerebral Injury in a Preclinical Model of Systemic Congestion

Safety and Feasibility Assessment of the Doraya, a Renal Venous Afterload Modulator, for the Treatment of Volume Overload in Acute Heart Failure Patients with Insufficient Response to Diuretics

The Nephronyx Perfuser: A Novel Device That Targets Increased Renal Venous Pressure in Patient With Cardiorenal Syndrome

Pulmonary to Venous Shunt for Group 2 PH-HFpEF (NXT™ Rivet)

Utilization of Left-Atrial Venous Arterial Extracorporeal Membrane Oxygenation for Biventricular Failure in Cardiogenic Shock

Reducing Renal Venous Pressure: Revamp/Doraya Infra-Renal Vein Flow Regulator

Medically Ill Patient Assessment of Rivaroxaban Versus Placebo IN Reducing Post-Discharge Venous Thrombo-Embolism Risk (MARINER) Trial: Primary Results

Prevention of Contrast-Induced Nephropathy by Central Venous Pressure (CVP)-Guided Fluid Administration

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content